Ryohei Katayama

36PUBLICATIONS
94CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsFormal methods for softwareSolid tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Jun 02, 2026
Afatinib Overcomes Osimertinib Resistance via Egfr V804F Mutation in a Syngeneic Egfr-Mutant Lung Cancer Mouse Model.

|May 22, 2026
Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr-mutated lung cancer.

|Jan 31, 2026
Concerted pH-Responsive Performance of Chitosan-Deoxycholic Acid as a Polymeric Molecular Block for Cancer Cell Disruption.

Watunyu Thanongsak, Marie Kawahara, Masahiko Nakamoto

|Jul 24, 2025
Inhibition of anti-apoptotic Bcl-2 family members promotes synergistic cell death with ER stress inducers by disrupting autophagy in glioblastoma.

Tianyi Huang, Satoshi Takagi, Sumie Koike

|Mar 04, 2025
Novel Approach to Overcome Osimertinib Resistance Using Bromodomain and Extra-Terminal Domain Inhibitors.

Yosuke Miyashita, Ken Tajima, Kenta Izumi

|Feb 04, 2025
AXL-Mediated Drug Resistance in ALK-Rearranged NSCLC Enhanced by GAS6 From Macrophages and MMP11 Positive Fibroblasts.

Takahiro Utsumi, Hayato Mizuta, Yosuke Seto

Pageof 6

Frequent Collaborators

12 joint publications

Naoya Fujita

6 joint publications

Makoto Nishio

4 joint publications

Kengo Takeuchi

4 joint publications

Satoshi Takagi